It's not unusual for trials to be stopped earlier for that exact reason. However, you can't just glance at a spreadsheet and say "it's working!".

Statistical analyses need to be pre-defined and powered to measure an effect.

I've been on clinical trials where the innovator drug showed a fantastic effect early on, then two overall survival curves crossed a year later.